Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control

BACKGROUND: It is unclear whether people with type 2 diabetes mellitus on insulin monotherapy who do not achieve adequate glycaemic control should continue insulin as monotherapy or can benefit from adding oral glucose‐lowering agents to the insulin therapy. OBJECTIVES: To assess the effects of insu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Vos, Rimke C, van Avendonk, Mariëlle JP, Jansen, Hanneke, Goudswaard, Alexander Nicolaas N, van den Donk, Maureen, Gorter, Kees, Kerssen, Anneloes, Rutten, Guy EHM
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2016
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457595/
https://ncbi.nlm.nih.gov/pubmed/27640062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006992.pub2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars